DcR3 regulates the growth and metastatic potential of SW480 colon cancer cells

被引：24

作者：

Yu, Wei ^{[1
]}

Xu, Ying-Chen ^{[2
]}

Tao, Ying ^{[1
]}

He, Ping ^{[2
]}

Li, Yang ^{[2
]}

Wu, Tao ^{[1
]}

Zhu, Yan-Pei ^{[1
]}

Li, Jing ^{[3
]}

Wu, Ji-Xiang ^{[4
]}

Dai, Jie ^{[1
]}

机构：

[1] Capital Med Univ, Ctr Clin Pathol, Beijing 100069, Peoples R China

[2] Capital Med Univ, Beijing Anzhen Hosp, Dept Gen Surg, Beijing 100029, Peoples R China

[3] Beijing Aerosp Gen Hosp, Dept Pathol, Beijing 100076, Peoples R China

[4] Capital Med Univ, Beijing Tongren Hosp, Beijing 100730, Peoples R China

来源：

ONCOLOGY REPORTS | 2013年 / 30卷 / 06期

基金：

中国国家自然科学基金;

关键词：

DcR3; colon cancer; RNAi; MMPs; VEGFs; DECOY RECEPTOR-3; CLINICAL-SIGNIFICANCE; ESOPHAGEAL-CARCINOMA; VEGF-D; PROLIFERATION; SUPERFAMILY; INHIBITION; EXPRESSION; MIGRATION; SURVIVAL;

D O I：

10.3892/or.2013.2769

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Decoy receptor 3 (DcR3) is considered to have anti-apoptotic and pro-metastatic functions, suggesting it might be a therapeutic target. We examined the role and mechanisms of DcR3 on growth and the metastatic ability of SW480 colon cancer cells to provide therapeutic information for targeting DcR3 by RNA interference (RNAi) technology. Growth and the metastatic ability were inhibited, apoptosis was induced and cell cycle profile was changed after decreasing DcR3 expression, with lower levels of vascular endothelial growth factors (VEGFs) and matrix metalloproteinases (MMPs) expression. Our results implied the therapeutic potential of silencing DcR3 expression by RNAi in colon cancer.

引用

页码：2741 / 2748

页数：8

共 50 条

[21] Methyl nomilinate inhibits SW480 colon cancer cells growth through modulation of cell cycle regulators
Kim, Jinhee
Jayaprakasha, G. K.
Vikram, Amit
Patil, Bhimanagouda S.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
[22] 5-Geranyloxy-7-Methoxycoumarin Inhibits Colon Cancer (SW480) Cells Growth by Inducing Apoptosis
Patil, Jaiprakash R.
Jayaprakasha, Guddadarangavvanahally K.
Kim, Jinhee
Murthy, Kotamballi N. Chidambara
Chetti, Mahadev B.
Nam, Sang-Yong
Patil, Bhimanagouda S.
PLANTA MEDICA, 2013, 79 (3-4) : 219 - 226
[23] Growth inhibition effect of DL-lysine acetylalicylate on sw480 colon carcinoma cells
Wang Shu
Tian Xiao-feng
Wang Li-ming
CHINESE JOURNAL OF CANCER RESEARCH, 2007, 19 (01) : 18 - 21
[24] Obtaining and characterization of spheroids using colon adenocarcinoma SW480 cells
Ceballos-Duque, Susana
Maldonado-Celis, Maria Elena
Montoya, Yuliet
REVISTA COLOMBIANA DE CANCEROLOGIA, 2023, 27 (03): : 389 - 396
[25] Growth Inhibition Effect of DL-Lysine Acetylalicylate on sw480 Colon Carcinoma Cells
王澍
田晓峰
王立明
Chinese Journal of Cancer Research, 2007, (01) : 18 - 21
[26] Quercetin and protein expression in human colon carcinoma SW480 cells
Mouat, M
Buck, E
Grider, A
Fischer, JG
Hargrove, JL
FASEB JOURNAL, 2003, 17 (05): : A1202 - A1202
[27] Thymosin β4 knockdown disrupts mitochondrial functions of SW480 human colon cancer cells
Tang, Mei-Chuan
Su, Yeu
CANCER SCIENCE, 2011, 102 (09) : 1665 - 1672
[28] Overexpression of the thymosin β-4 gene is associated with malignant progression of SW480 colon cancer cells
Wei-Shu Wang
Po-Min Chen
Hung-Liang Hsiao
Sy-Yeuan Ju
Yeu Su
Oncogene, 2003, 22 : 3297 - 3306
[29] Quercetin, a potent inhibitor against β-catenin/Tcf signaling in SW480 colon cancer cells
Park, CH
Chang, JY
Hahm, ER
Park, S
Kim, HK
Yang, CH
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 328 (01) : 227 - 234
[30] Celecoxib-induced growth inhibiton in SW480 colon cancer cells is associated with activation of protein kinase G
Kazi, G. Julhash U.
Weinstein, IBernard
Soh, Jae-Won
MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3609S - 3609S

← 1 2 3 4 5 →